XORTX THERAPEUTICS INC (XRTX.CA) Stock Analyst Ratings
Canada - TSX Venture Exchange - TSX-V:XRTX - CA98420Q3061 - Common Stock
0.85 CAD
-0.03 (-3.41%)
ChartMill assigns a Buy % Consensus number of 80% to XRTX.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
XRTX.CA was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about XRTX.CA.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed XRTX.CA. So this is just the average opinion of a couple of analysts.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-04-22 | Alliance Global Partbers | Initiate | Buy |
XORTX THERAPEUTICS INC / XRTX.CA FAQ
What is the consensus rating for XORTX THERAPEUTICS INC (XRTX.CA) stock?
The consensus rating for XORTX THERAPEUTICS INC (XRTX.CA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for XORTX THERAPEUTICS INC stock?
The number of analysts covering XORTX THERAPEUTICS INC (XRTX.CA) is 5.